Management Team / Advisory Board Bios
Dalton Shaull, CEO, President, Co-Founder
Mr. Shaull, BS, is an organ transplant subject matter expert who provides clinical knowledge per his direct experience as a transplant recipient. Dalton also has a background in medical device and technology sales as employee at a disruptive startup HLT, Inc., Stryker Medical, and Intuitive DaVinci Robotics. Mr. Shaull has a strong connected purpose as a transplant recipient and an uncle who is a transplant surgeon. Mr. Shaull is a full-time employee focused on fundraising, sales, talent management and recruiting, and business dev. Mr. Shaull was included in the 2018 Forbes 30UNDER30 Healthcare Leaders .
Eric Pahl, PhD* Chief Security, Compliance, Research Officer, Secretary, Co-Founder
Mr. Pahl is a biomedical engineer and current doctoral fellow of health informatics at the University of Iowa. He has been active in the development of health software applications as an engineer and leader including disruptive health technology company iDx. He also brings direct experience with organ donation and transplantation as a family member of several family members diagnosed and battling liver failure. Mr. Pahl brings a network of technical expertise, investors, and university resources to the business and is focused on product, research, and business development. Mr. Pahl was included in the 2018 Forbes 30UNDER30 Healthcare Leaders.
Dr Robert W Emery, Chief Scientific Officer
Dr. Emery is our principal investigator for our NIH SBIR Phase 1 $250,000 grant that was awarded to the company in 2017 as well as the recently awarded $1.5M NIH SBIR Phase II grant. Dr Emery was part of the leadership team that started the very first organ procurement organization. He continues to provide value through his extensive network of world-class transplant surgeons, presentations of our research at key conferences across the country, and introduction to transplant professionals.
Beau Barron, MBA, Director of Sales
Mr. Barron graduated from University of Georgia with a BS in Business and Masters in Business Administration. Mr. Barron brings direct experience and a strong connected purpose as a transplant recipient as well as a former FireFighter and EMT. Mr. Barron has over 10 years of medical device and technology sales at AngioDynamics, Teleflex, and health technology consulting at Cumberland.
Gary Ditsch, Director of Product
Mr. Ditsch graduated with a BS in Exercise Science at Nebraska University before moving to Lexington, KY to accept a job as Fitness Director at University of Kentucky where he also earned his Masters degree in Health Promotion. Gary then joined Retrofit which was acquired by Livlongo. In 2019, Livlongo goes public and in 2020, and in August 2020, Livlong announces $18.5B merger with Teledoc. Gary brings technical and market expertise with our products serving transplant centers and key stakeholders involved in the management of diabetes and ESRD.
Nick Jones, Director of Engineering
Mr. Jones has a Masters degree in chemistry and computer science from the University of Oxford. Mr. Jones brings direct experience as a father of a kidney recipient due to a rare kidney disease.
Greg Janes, MBA, Director of Marketing
Greg is a serial startup veteran who helped 3 prior startups to be acquired after he implemented S&M programs that drove hyper-revenue growth. Most recently, Greg helped a health IT company to grow from pre-revenue to a multi-million revenue run rate in < 2 years, resulting in a successful acquisition by Cardinal Health. Greg holds an MBA in International Business & Marketing from the Monterey Institute and a B.A. in Marketing from Iowa State. Greg brings experience in marketing from his experience in growing a health technology company Telepharm through acquisition by Cardinal Health in 2018.
